vs
Side-by-side financial comparison of FREQUENCY ELECTRONICS INC (FEIM) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
Entrada Therapeutics, Inc. is the larger business by last-quarter revenue ($20.6M vs $17.1M, roughly 1.2× FREQUENCY ELECTRONICS INC). FREQUENCY ELECTRONICS INC runs the higher net margin — 10.5% vs -84.4%, a 94.9% gap on every dollar of revenue. On growth, FREQUENCY ELECTRONICS INC posted the faster year-over-year revenue change (8.3% vs -65.2%). FREQUENCY ELECTRONICS INC produced more free cash flow last quarter ($-1.1M vs $-39.7M). Over the past eight quarters, FREQUENCY ELECTRONICS INC's revenue compounded faster (11.8% CAGR vs 6.4%).
Ultra Electronics Holdings is a British defence and security company. It was listed on the London Stock Exchange and was a constituent of the FTSE 250 Index until it was acquired by Cobham, which is itself owned by Advent International.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
FEIM vs TRDA — Head-to-Head
Income Statement — Q2 FY2026 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $17.1M | $20.6M |
| Net Profit | $1.8M | $-17.3M |
| Gross Margin | 38.2% | — |
| Operating Margin | 10.0% | -106.0% |
| Net Margin | 10.5% | -84.4% |
| Revenue YoY | 8.3% | -65.2% |
| Net Profit YoY | -32.1% | -173.8% |
| EPS (diluted) | $0.18 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $17.1M | — | ||
| Q3 25 | $13.8M | — | ||
| Q2 25 | $20.0M | — | ||
| Q1 25 | $18.9M | $20.6M | ||
| Q4 24 | $15.8M | $37.4M | ||
| Q3 24 | $15.1M | $19.6M | ||
| Q2 24 | $15.6M | $94.7M | ||
| Q1 24 | $13.7M | $59.1M |
| Q4 25 | $1.8M | — | ||
| Q3 25 | $634.0K | — | ||
| Q2 25 | $3.2M | — | ||
| Q1 25 | $15.4M | $-17.3M | ||
| Q4 24 | $2.7M | $1.1M | ||
| Q3 24 | $2.4M | $-14.0M | ||
| Q2 24 | $2.6M | $55.0M | ||
| Q1 24 | $130.0K | $23.5M |
| Q4 25 | 38.2% | — | ||
| Q3 25 | 36.8% | — | ||
| Q2 25 | 37.5% | — | ||
| Q1 25 | 43.8% | — | ||
| Q4 24 | 48.2% | — | ||
| Q3 24 | 44.4% | — | ||
| Q2 24 | 40.3% | — | ||
| Q1 24 | 22.6% | — |
| Q4 25 | 10.0% | — | ||
| Q3 25 | 2.6% | — | ||
| Q2 25 | 16.4% | — | ||
| Q1 25 | 18.3% | -106.0% | ||
| Q4 24 | 16.5% | -15.7% | ||
| Q3 24 | 15.7% | -110.7% | ||
| Q2 24 | 16.0% | 56.4% | ||
| Q1 24 | -3.4% | 35.7% |
| Q4 25 | 10.5% | — | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 16.0% | — | ||
| Q1 25 | 81.4% | -84.4% | ||
| Q4 24 | 16.8% | 3.0% | ||
| Q3 24 | 16.1% | -71.7% | ||
| Q2 24 | 16.9% | 58.1% | ||
| Q1 24 | 0.9% | 39.7% |
| Q4 25 | $0.18 | — | ||
| Q3 25 | $0.07 | — | ||
| Q2 25 | $0.33 | — | ||
| Q1 25 | $1.60 | $-0.42 | ||
| Q4 24 | $0.28 | $-0.20 | ||
| Q3 24 | $0.25 | $-0.35 | ||
| Q2 24 | $0.28 | $1.55 | ||
| Q1 24 | $0.01 | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0M | $67.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $58.5M | $417.3M |
| Total Assets | $92.3M | $486.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | — | ||
| Q3 25 | $4.5M | — | ||
| Q2 25 | $4.7M | — | ||
| Q1 25 | $5.5M | $67.8M | ||
| Q4 24 | $9.7M | $101.2M | ||
| Q3 24 | $16.2M | $78.0M | ||
| Q2 24 | $18.3M | $185.3M | ||
| Q1 24 | $11.7M | $68.4M |
| Q4 25 | $58.5M | — | ||
| Q3 25 | $56.3M | — | ||
| Q2 25 | $55.6M | — | ||
| Q1 25 | $51.8M | $417.3M | ||
| Q4 24 | $36.2M | $428.7M | ||
| Q3 24 | $33.2M | $422.4M | ||
| Q2 24 | $39.8M | $429.9M | ||
| Q1 24 | $36.7M | $269.4M |
| Q4 25 | $92.3M | — | ||
| Q3 25 | $93.2M | — | ||
| Q2 25 | $93.7M | — | ||
| Q1 25 | $86.4M | $486.5M | ||
| Q4 24 | $77.8M | $526.3M | ||
| Q3 24 | $84.3M | $554.6M | ||
| Q2 24 | $83.3M | $582.0M | ||
| Q1 24 | $77.7M | $510.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-523.0K | $-38.5M |
| Free Cash FlowOCF − Capex | $-1.1M | $-39.7M |
| FCF MarginFCF / Revenue | -6.6% | -192.9% |
| Capex IntensityCapex / Revenue | 3.6% | 5.6% |
| Cash ConversionOCF / Net Profit | -0.29× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-5.5M | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-523.0K | — | ||
| Q3 25 | $1.2M | — | ||
| Q2 25 | $-155.0K | — | ||
| Q1 25 | $-3.6M | $-38.5M | ||
| Q4 24 | $3.8M | $-31.6M | ||
| Q3 24 | $-1.5M | $-24.3M | ||
| Q2 24 | $7.5M | $39.8M | ||
| Q1 24 | $4.2M | $-25.5M |
| Q4 25 | $-1.1M | — | ||
| Q3 25 | $385.0K | — | ||
| Q2 25 | $-786.0K | — | ||
| Q1 25 | $-4.0M | $-39.7M | ||
| Q4 24 | $3.3M | $-32.2M | ||
| Q3 24 | $-1.8M | $-24.9M | ||
| Q2 24 | $6.7M | $38.8M | ||
| Q1 24 | $3.9M | $-26.4M |
| Q4 25 | -6.6% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | -20.9% | -192.9% | ||
| Q4 24 | 20.8% | -86.2% | ||
| Q3 24 | -11.8% | -127.3% | ||
| Q2 24 | 42.8% | 41.0% | ||
| Q1 24 | 28.4% | -44.6% |
| Q4 25 | 3.6% | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | 3.2% | — | ||
| Q1 25 | 1.7% | 5.6% | ||
| Q4 24 | 3.3% | 1.7% | ||
| Q3 24 | 2.2% | 3.3% | ||
| Q2 24 | 5.3% | 1.1% | ||
| Q1 24 | 2.3% | 1.4% |
| Q4 25 | -0.29× | — | ||
| Q3 25 | 1.83× | — | ||
| Q2 25 | -0.05× | — | ||
| Q1 25 | -0.24× | — | ||
| Q4 24 | 1.44× | -27.94× | ||
| Q3 24 | -0.60× | — | ||
| Q2 24 | 2.85× | 0.72× | ||
| Q1 24 | 32.36× | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FEIM
| POC Revenue | $14.8M | 86% |
| POT Revenue | $2.3M | 13% |
TRDA
Segment breakdown not available.
